Navigation path

Pharma-Planta

Recombinant Pharmaceuticals from Plants

Stand number: 13


Pharma-Planta

Pharma-Planta aims to develop an approved production process for pharmaceutical proteins made in plants, culminating in a phase I human clinical trial. We have succeeded in the development of a tobacco-based production platform and have recently initiated clinical testing of our first product, an antibody that acts against HIV. Our demonstration outlines the production process and shows how the antibody is purified from plants.

Website

Contact